Spots Global Cancer Trial Database for genital diseases, female
Every month we try and update this database with for genital diseases, female cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers | NCT01523678 | Ovarian Cancer Endometrial Can... Uterine Cervica... | Filgrastim Paclitaxel Carboplatin | 18 Years - | Belgian Gynaecological Oncology Group | |
| Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients | NCT01523652 | Genital Disease... Ovarian Neoplas... Urogenital Neop... | 18 Years - | Azienda Ospedaliera San Giovanni Battista | ||
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer | NCT03562897 | Carcinoma Ovarian Neoplas... Endocrine Gland... Urogenital Neop... Ovarian Disease... Adnexal Disease... Genital Disease... Female Urogenit... Female Urogenit... Endocrine Syste... Gonadal Disorde... Genital Neoplas... Neoplasms, Glan... | Ocoxin-Viusid | 18 Years - | Catalysis SL | |
| Prospective Validation and Comparison of Different Ultrasound Methods for Discrimination Between Benign and Malignant Ovarian/Tubal Masses Prior to Surgery | NCT02847832 | Patients With A... | Standardized tr... | - | KU Leuven | |
| SMS-based Summons in Cervical Screening | NCT04061967 | Cervical Cancer Uterine Cervica... Uterine Neoplas... Genital Neoplas... Genital Neoplas... Uterine Disease... Genital Disease... Neoplasms by Si... Neoplasms Uterine Cervica... | Sending of scre... | 33 Years - 75 Years | Karolinska Institutet | |
| Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia | NCT02139267 | Cervical Intrae... | GX-188E | 19 Years - 50 Years | Genexine, Inc. | |
| A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) | NCT00749502 | Solid Tumors Chronic Lymphoc... T-cell-prolymph... | MK-4827 | 18 Years - | Tesaro, Inc. | |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer | NCT03562897 | Carcinoma Ovarian Neoplas... Endocrine Gland... Urogenital Neop... Ovarian Disease... Adnexal Disease... Genital Disease... Female Urogenit... Female Urogenit... Endocrine Syste... Gonadal Disorde... Genital Neoplas... Neoplasms, Glan... | Ocoxin-Viusid | 18 Years - | Catalysis SL | |
| Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer | NCT01462890 | Genital Disease... Ovarian Disease... Ovarian Neoplas... Fallopian Tube ... Peritoneal Neop... | Bevacizumab Paclitaxel Carboplatin specialized pat... | 18 Years - | AGO Study Group | |
| Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia | NCT02139267 | Cervical Intrae... | GX-188E | 19 Years - 50 Years | Genexine, Inc. | |
| Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma | NCT01460979 | Genital Disease... Ovarian Disease... Ovarian Neoplas... Endometrial Neo... | Temsirolimus | 18 Years - | AGO Study Group | |
| Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia | NCT02139267 | Cervical Intrae... | GX-188E | 19 Years - 50 Years | Genexine, Inc. | |
| SMS-based Summons in Cervical Screening | NCT04061967 | Cervical Cancer Uterine Cervica... Uterine Neoplas... Genital Neoplas... Genital Neoplas... Uterine Disease... Genital Disease... Neoplasms by Si... Neoplasms Uterine Cervica... | Sending of scre... | 33 Years - 75 Years | Karolinska Institutet |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
